Glucocorticoid Dependency as A Prognostic Factor in Radiotherapy for Cerebral Gliomas
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 28 (1) , 51-55
- https://doi.org/10.3109/02841868909111181
Abstract
Records of 76 consecutive patients treated with radiotherapy for cerebral gliomas were reviewed. Eleven patients had no tissue diagnosis, and their outcome was comparable to that of patients with glioblastoma. Patients with other histologic diagnoses had much better results. Among the entire study population, the most important prognostic factors included age and histologic grade. Even with stratification by histologic grade and age, glucocorticoid (steroid) dependency was a reliable prognostic indicator in terms of survival. Fifteen of the 47 patients (32%) who were less steroid dependant are still alive with a median survival time of 29 months. Among the 29 patients who were heavily dependant on steroids during the course of radiotherapy, the median survival time was 5 months with only 2 patients (7%) still alive.Keywords
This publication has 17 references indexed in Scilit:
- Modification of the Gouda Frame to Allow Stereotactic Biopsy of the Brain Using the GE 8800 Computed Tomographic ScannerNeurosurgery, 1983
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980
- Assumptions in the radiotherapy of glioblastomaNeurology, 1980
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978
- Corticosteroid HormonesArchives of Neurology, 1974
- Corticosteroid Effect on Transplantable Rat GliomaArchives of Neurology, 1971
- The Effect of Glucocorticosteroids on Growth and Metabolism of Experimental Glial TumorsJournal of Neurosurgery, 1969
- Tumor Extent as A Determining Factor in Radiotherapy of GlioblastomasActa Radiologica: Therapy, Physics, Biology, 1969
- The Treatment of Glioblastoma Multiforme of the BrainJournal of Neurosurgery, 1967
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948